Endothelial progenitor cell senescence — is there a role for estrogen?

Therapeutic Advances in Cardiovascular Disease

Volumn 4, Issue 1, 2010, Pages 55-69

  Imanishi, Toshio ^a   Tsujioka, Hiroto ^a   Akasaka, Takashi ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Endothelial progenitor cell; Estrogen; Senescence; Telomerase

Indexed keywords

ESTROGEN; REACTIVE OXYGEN METABOLITE; TELOMERASE;

BLOOD VESSEL INJURY; CELL AGING; CELL THERAPY; CLINICAL TRIAL; ENDOTHELIAL STEM CELL; ENZYME ACTIVITY; HUMAN; IN VITRO STUDY; ISCHEMIA; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL; TISSUE REPAIR; ANGIOGENESIS; ANIMAL; CYTOLOGY; DRUG EFFECT; METABOLISM; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANIMALS; CELL AGING; ENDOTHELIUM, VASCULAR; ESTROGENS; HUMANS; ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; REACTIVE OXYGEN SPECIES; STEM CELLS; TELOMERASE;

EID: 77949894531     PISSN: 17539447     EISSN: None     Source Type: Journal    
DOI: 10.1177/1753944709353173     Document Type: Review

References (110)

1. Ali, J., Liao, F., Martens, E. and Muller, W.A. ( 1997) Vascular endothelial cadherin (VE-cadherin): cloning and role in endothelial cell-cell adhesion. Microcirculation 4: 267-277.
2. Amrani, M., Goodwin, A.T., Gray, C.C. and Yacoub, M.H. ( 1996) Aging is associated with reduced basal and stimulated release of nitric oxide by the coronary endothelium. Acta Physiol Scand 157: 79-84.
3. Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T. et al. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967.
4. Bahlmann, F.H., de Groot, K., Mueller, O.H., Hertel, B., Haller, H. and Fliser, D. (2005) Stimulation of endothelial progenitor cells - a new putative therapeutic effect of angiotensin II receptor antagonism. Hypertension 45: 526-529.
5. Ballard, V.L.T. and Edelberg, J.M. ( 2007) Stem cells and the regeneration of the aging cardiovascular system. Circ Res 100: 1116-1127.
6. Bauer, K.A., Weiss, L.M., Sparrow, D., Vokonas, P.S. and Rosenberg, R.D. ( 1987) Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study. J Clin Invest 80: 1527-1534.
7. Benetos, A., Okuda, K., Lejemi, M., Kimura, M., Thomas, F., Skumick, J. et al. (2001) Telomere length as an indicator of biological aging: the gender effect and relation with pulse pressure and pulse wave velocity. Hypertension 37: 381-385.
8. Bernardini, D., Ballabio, E., Mariotti, M. and Maier, J.A. ( 2005) Differential expression of EDF-1 and endothelial nitric oxide synthase by proliferating, quiescent, and senescent microvascular endothelial cells. Biochim Biophys Acta 1745: 265-272.
9. Besler, C., Doerries, C., Giannotti, G., Luscher, T.F. and Landmesse, U. ( 2008) Pharmacological approaches to improve endothelial repair mechanisms. Expert Rev Cardiovasc Ther 6: 1071-1082.
10. Billon, A., Lehoux, S., Lam Shang Leen, L., Laurell, H., Filipe, C., Benouaich, V. et al. (2008) The estrogen effects on endothelial repair and mitogen-activated protein kinase activation are abolished in endothelial nitric-oxide (NO) synthase knockout mice, but not by NO synthase inhibition by N-nitro-L-arginine methyl ester. Am J Pathol 172: 830-838.
11. Blokhina, O., Virolainen, E. and Fagerstedt, K.Y. ( 2003) Antioxidants, oxidative damage and oxygen deprivation stress: a review. Ann Bot (Lond) 91: 179-194.
12. Chang, E. and Harley, C.B. ( 1995) Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci USA 92: 11190-11194.
13. Chen, J.Z., Zhang, F.R., Tao, Q.M., Wang, X.X. and Zhu, J.H. ( 2004) Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolemia. Clin Sci Lond 107: 273-280.
14. Cherif, H., Tary, J.I., Ozamne, S.E. and Hales, C.N. ( 2003) Ageing and telomeres: a study into organ- and gender-specific telomere shortening. Nucleic Acids Res 31: 1576-1583.
15. Colak, E., Majkic-Singh, N., Stankovic, S., Sreckovic-Dimitrijevie, V., Djordjevic, P.B., Lalik, K. et al. (2005) Parameters of antioxidative defence in type 2 diabetes patients with cardiovascular complications. Ann Med 37: 613-620.
16. Cooke, C.L. and Davidge, S.T. ( 2002) Peroxynitrite increases iNOS through NF-κB and decreases prostacyclin synthase in endothelial cells. Am J Physiol Cell Physiol 282: C395-C402.
17. Coviello-McLaughlin, G.M. and Prowse, K.R. ( 1997) Telomere length regulation during postnatal development and ageing in Mus spretus. Nucleic Acids Res 25: 3051-3058.
18. Dernbach, E., Urbich, C., Brandes, R.P., Hofmann, W.K., Zeiher, A.M. and Dimmeler, S. ( 2004) Antioxidative stress-associated genes in circulating progenitor cells: Evidence for enhanced resistance against oxidative stress. Blood 104: 3591-3597.
19. Doshida, M., Ohmichi, M., Tsutsumi, S., Kawagoe, J., Takahashi, T., Du, B. et al. (2006) Raloxifene increases proliferation and up-regulation of telomerase activity in human umbilical vein endothelial cells. J Biol Chem 281: 24270-24278.
20. Dubey, R.K. and Jackson, E.K. ( 2001) Estrogen-induced cardiorenal protection: potential cellular biochemical, and molecular mechanisms. Am J Physiol Renal Physio 280: F365-F388.
21. Edelberg, J.M., Tang, L., Hatton, K., Lyden, D. and Rafii, S. ( 2002) Young adult bone marrow-derived endothelial precursor cells restore aging-impaired cardiac angiogenic function. Circ Res 90: E89-E93
22. Egami, K., Murohara, T., Shimada, T., Sasaki, K., Shintani, S., Sugaya, T. et al. (2003) Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J Clin Invest 112: 67-75.
23. Erusalimsky, J.D. and Kurz, D.J. ( 2006) Endothelial cell senescence. Handb Exp Pharmacol 176: 213-248.
24. Fadini, G.P., Kreutzenberg, S., Albiero, M., Coracina, A., Pagnin, E., Baesso, I. et al. (2008) Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens. Arterioscler Thromb Vasc Biol 28: 997-1004.
25. Fadini, G.P., Albiero, M., Cignarella, A., Bolego, C., Pinna, C., Boscaro, E. et al. (2009) Effects of androgens on endothelial progenitor cells in vitro and in vivo. Clin Sci (in press).
26. Fadini, G.P., Coracina, A., Baesso, I., Agostini, C., Tiengo, A., Avogaro, A. et al. (2006) Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population. Stroke 37: 2277-2282.
27. Farhat, M.Y., Lavigne, M.C. and Ramwell, P.W. ( 1996) The vascular protective effects of estrogen. FASEB J 10: 615-624.
28. Feng, J., Funk, W.D., Wang, S.S., Weinrich, S.L., Avillon, A.A., Chiu, C.P. et al. (1995) The RNA component of human telomerase. Science 269: 1236-1241.
29. Fontaine, V., Filipe, C., Werner, N., Gourdy, P., Billon, A., Garmy-Suini, B. et al. (2006) Essential role of bone marrow fibroblast growth factor-2 in the effect of estradiol on re-endotheliazation and endothelial progenitor cell mobilization. Am J Pathol 169: 1855-1862.
30. Foresta, C., Caretta, N., Lana, A., de Toni, L., Biagioli, A., Ferlin, A. and Garolla, A. ( 2006) Reduced number of circulating endothelial cells in hypogonadal men. J Clin Endocrinol Metab 91: 4599-4602.
31. Foresta, C., Zuccarello, D., de Toni, L., Garolla, A., Caretta, N. and Ferlin, A. ( 2007) Androgen stimulate endothelial progenitor cells through an androgen receptor-mediated pathway. Clin Endocrinol 68: 284-289.
32. Foresta, C., Toni, L., Di Mambro, A., Ferlin, A., Perilli, L., Bertuzzi, I. et al. (2008) Role of estrogen receptors in menstrual cycle-related neoangiogenesis and their influence on endothelial progenitor cell physiology. Fertil Steril (in press).
33. Galasso, G., Schiekofer, S., Sato, K., Shibata, R., Hasndy, D.E., Ouchi, N. et al. (2006) Impaired angiogenesis in glutathione peroxidase-1-deficient mice is associated with endothelial progenitor cell dysfunction. Circ Res 98: 254-261.
34. Gargett, C.E., Zaitseva, M., Bucak, K., Chu, S., Fuller, P.J. and Rogers, P.A. ( 2002) 17Beta-estradiol up-regulates vascular endothelial growth factor-2 expression in human myometrial microvascular endothelial cells: role of estrogen receptor-alpha and -beta. J Clin Endocrinol Metab 87: 4341-4349.
35. Geider, C.W. ( 1998) Telomerase activity, cell proliferation, and cancer. Proc Natl Acad Sci USA 95: 90-92.
36. Goldschmidt-Clermont, P.J., Lam, G. and Dong, C. ( 2003) Progenitor cell dysfunction: a key trigger for atherosclerotic inflammation. Am Heart J 146: S5-12.
37. Gragasin, F.S., Xu, Y., Arenas, I.A., Kainth, N. and Davidge, S.T. ( 2003) Estrogen reduces angiotensin II-induced nitric oxide synthase and NAD(P)H oxidase expression in endothelial cells. Arterioscler Thromb Vasc Biol 23: 38-44.
38. Hager, K., Setzer, J., Vogl, T., Voit, J. and Platt, D. ( 1989) Blood coagulation factors in the elderly. Arch Gerontol Geriatr 9: 277-282.
39. Hamada, H., Kim, M.K., Iwakura, A., Ii, M., Throne, T., Qin, G. et al. (2006) Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction. Circulation 114: 2261-2270.
40. Hayflik, L. and Moorhead, P. ( 1961) The serial cultivation of human diploid strains. Exp Cell Res 25: 585-621.
41. He, T., Peterson, T.E., Holmuhamedov, E.L., Terzic, A., Caplice, N.M., Oberley, L.W. et al. (2004) Human endothelial progenitor cells tolerate oxidative stress due to intrinsically high expression of manganese superoxide dismutase. Arterioscler Thromb Vasc Biol 24: 2021-2027.
42. Heeschen, C., Lehmann, R., Honold, J., Assmus, B., Aicher, A., Walter, D.H. et al. (2004) Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 109: 1615-1622.
43. Heiss, C., Keymel, S., Niesler, U., Ziemann, J., Kelm, M. and Kalka, C. ( 2005) Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol 45: 1441-1448.
44. Heitzer, T., Wenzel, U., Hink, U., Krollner, D., Skatchkov, M., Stahl, R.A. et al. (1999) Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C. Kidney Int 55: 252-260.
45. Histov, M., Erl, W. and Weber, P.C. ( 2003) Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioslcer Throm Basc Biol 23: 1185-1189.
46. Hoetzer, G.L., MacEneaney, O.J., Irmiger, H.M., Keith, R., van Guilder, G.P., Stauffer, B.L. et al. (2007) Gender differences in circulating endothelial progenitor cell colony-forming capacity and migratory activity in middle-aged adults. Am J Cardiol 99: 46-48.
47. Hulley, S., Furberg, C., Barrett-Connor, E., Cauley, J., Grady, D., Haskell, W. et al.; HERS Research Group (2002) Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen / progestin Replacement Study follow-up (HERS II). JAMA 288: 58-66.
48. Hulley, S., Grady, D., Bush, T., Furberg, C., Herrington, D., Riggs, B. et al. (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen / progestin Replacement Study (HERS) Research Group. JAMA 280: 605-613.
49. Hur, J., Yoon, C.H., Kim, H.S., Choi, J.H., Kang, H.J., Hwang, K.K. et al. (2004) Characterization of two types of endothelial progenitor cells and their different contribution to neovasculogenesis. Arterioscler Thromb Vasc Biol 24: 288-293.
50. Ichiki, T., Usui, M., Kato, M., Funakoshi, Y., Ito, K., Egashira, K. et al. (1998) Downregulation of angiotensin II type 1 receptor gene transcription by nitric oxide. Hypertension 31: 342-348.
51. Ihionkhan, C.E., Chambliss, K.L., Gibson, L.L., Hahner, L.D., Mendelsohn, M.E. and Shaul, P.W. ( 2002) Estrogen causes dynamic alterations in endothelial estrogen receptor expression. Circ Res 91: 814-820.
52. Imanishi, T., Hano, T. and Nishio, I. ( 2005a) Estrogen reduces endothelial progenitor cell senescence through augmentation of telomerase activity. J Hypertens 23: 1699-1706.
53. Imanishi, T., Tsujioka, H. and Akasaka, T. ( 2008) Endothelial progenitor cells and senescence: contribution to oxidative stress. Curr Cardiol Rev 4: 275-286.
54. Imanishi, T., Moriwaki, C., Hano, T. and Nishio, I. ( 2005b) Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with hypertension. J Hypertens 23: 1831-1837.
55. Imanishi, T., Hano, T. and Nishio, I. ( 2005c) Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress. J Hypertens 23: 97-104.
56. Imanishi, T., Hano, T. and Nishio, I. ( 2005d) Estrogen reduces angiotensin II-induced acceleration of senescence in endothelial progenitor cells. Hypertes Res 28: 263-271.
57. Ingram, D.A., Krier, T.R., Mead, L.E., McGuire, C., Prater, D.N., Bhavsar, J. et al. (2007) Clonogenic endothelial progenitor cells are sensitive to oxidative stress. Stem Cells 25: 297-304.
58. Iwakura, A., Luedemann, C., Shastry, S., Hanley, A., Kearney, M., Aikawa, R. et al. (2003) Estrogen-mediated, endothelial nitiric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to re-endotheliazation after arterial injury. Circulation 108: 3115-3121.
59. Iwakura, A., Shubha, S., Luedemann, C., Hamada, H., Kawamoto, A., Kishore, R. et al. (2006) Estradiol enhances recovery after myocardial infarction by augmenting incorporation of bone marrow-derived endothelial progenitor cells into sites of ischemia-induced neovascularization via endothelial nitric oxide synthase-mediated activation of matrix metalloproteinase-9. Circulation 113: 1605-1614.
60. Jeanclos, E., Schork, N.J., Kyvik, K.O., Kimura, M., Skumick, J.H. and Aviv, A. ( 2000) Telomere length inversely correlates with pulse pressure and is highly familial. Hypertension 36: 195-200.
61. Kang, S.S., Kwon, T., Kwon, D.Y. and Do, S.I. ( 1999) Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J Biol Chem 274: 13085-13090.
62. Khan, M.A., Liu, M.W., Singh, D., Pal, A., Chio, F.L., Lawson, D. et al. (2000) Long-term (three years) effect of estrogen replacement therapy on major adverse cardiac events in postmenopausal women after intracoronary stenting. Am J Cardiol 86: 330-333.
63. Kushner, E.J., van Guilder, G.P., MacEneaney, O.J., Cech, J.N., Stauffer, B.L. and de Souza, C.A. (2009) Aging and endothelial progenitor cell telomere length in healthy men. Clin Chem Lab Med 47: 47-50.
64. Kyo, S., Takakura, M., Kanaya, T., Zhuo, W., Fujimoto, K., Nishio, Y. et al. (1999) Estrogen activates telomerase. Cancer Res 59: 5917-5921.
65. Lan Shang Leen, L., Filipe, C., Billon, A., Garmy-Susini, B., Jalvy, S., Robbesyn, F. et al. (2008) Estrogen-stimulated endothelial repair requires osteopontin. Arterioscler Thromb Vasc Biol 28: 2131-2136.
66. Lantin-Hermoso, R.L., Rosenfield, C.R., Yuhanna, I.S., German, Z., Chen, Z. and Shaul, P.W. ( 1997) Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. Am J Physiol 273: L119-L126.
67. Lassegue, B. and Clempus, R.E. ( 2003) Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol 285: R277-R297.
68. Leri, A., Malhotra, A., Liew, C.C., Kajstura, J. and Anversa, P. ( 2000) Telomerase activity in rat cardiac myocytes is age- and gender-dependent. J Moll Cell Cardiol 32: 385-390.
69. Li, D., Saldeen, T., Romeo, F. and Mehta, J.L. ( 2000) Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-κB. Circulation 102: 1970-1976.
70. Lin, Y., Weisdorf, D.J., Solovey, A. and Hebbel, R.P. ( 2000) Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 105: 71-77.
71. Linke, A., Adams, V., Schulze, P.C., Erbs, S., Gielen, S., Fiehn, E. et al. (2005) Antioxidative effects of exercise training in patients with chronic heart failure: increase in radical scavenger enzyme activity in skeletal muscle. Circulation 111: 1763-1770.
72. Ma, F.X., Zhou, B., Chen, Z., Ren, Q., Lu, S.H., Sawamura, T. and Han, Z.C. ( 2006) Oxidized low density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase. J Lipid Res 47: 1227-1237.
73. Masuda, H., Kalka, C., Takahashi, T., Yoshida, M., Wada, M., Kobori, M. et al. (2007) Estrogen-mediated endothelial progenitor cell biology and kinetics for physiological postnatal vasculogenesis. Circ Res 101: 598-606.
74. Matsumori, K., Yu, E.Y., Khurts, S., Ben-Porath, I., Currier, J.L., Metz, G.B. et al. (2003) Telomerase maintains telomere structure in normal human cells. Cell 114: 241-253.
75. Matsushita, H., Chang, E., Glassford, A.J., Cooke, J.P., Chiu, C.P. and Tsao, P.S. ( 2001) eNOS activity is reduced in senescent human endothelial cells: preservation by hTERT immortalization. Circ Res 89: 793-798.
76. Mendelsohn, M.E. and Karas, R.H. ( 1999) The protective effects of estrogen on the cardiovascular system. N Engl J Med 10: 615-624.
77. Min, T.Q., Zhu, C.J., Xiang, W.X., Hui, Z.J. and Peng, S.Y. ( 2004) Improvement in endothelial progenitor cells from peripheral blood by ramipril therapy in patients with stable coronary artery disease. Cardiovasc Drugs Ther 18: 203-209.
78. Miller, V.M. and Duckles, S.P. ( 2008) Vascular actions of estrogens: functional implications. Pharmacol Rev 60: 210-241.
79. Mooradian, A.D. ( 1993) Antioxidant properties of steroids. J Steroid Biochem Mol Biol 45: 509-511.
80. Murasawa, S., Llevadot, J., Silver, M., Isner, M., Losordo, D.W. and Asahara, T. ( 2002) Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells. Circulation 106: 1133-1139.
81. Nakamura, T.M., Morin, G.B., Chapman, K.B., Weinrich, S.L., Andrews, W.H., Linger, J. et al. (1997) Telomerase catalytic subunit homologs from fission yeast and human. Science 277: 955-959.
82. Nathan, L. and Chaudhuri, G. ( 1997) Estrogen and atherosclerosis. Ann Rev Pharmacol Toxicol 37: 477-515.
83. Nawrot, T.S., Staessen, J.A., Gardner, J.P. and Aviv, A. ( 2004) Telomere length and possible link to X chromosome. Lancet 363: 507-510.
84. Noble, M., Smith, J., Power, J. and Mayer-Proschel, M. ( 2003) Redox state as a central modulator of precursor cell function. Ann NY Acad Sci 991: 251-271.
85. Papapetropoulos, A., Garcia-Cardena, G., Madri, J.A. and Sessa, W.C. ( 1997) Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 100: 3131-3139.
86. Rauscher, F.M., Goldschmidt-Clermont, P.J., Davis, B.H., Wang, T., Gregg, D., Ramaswami, P. et al. (2003) Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 108: 457-463.
87. Robb, A.O., Mills, N.L., Smith, I.B., Short, A., Tura-Ceide, O., Barclay, G.R. et al. (2009) Influence of menstrual cycle on circulating endothelial progenitor cells. Hum Reprod 24: 619-625.
88. Rodgers, K.E., Xiong, S., Steer, R. and diZerega, G.S. ( 2000) Effect of angiotensin II on hematopoietic progenitor cell proliferation. Stem Cells 18: 287-294.
89. Ruiz-Ortega, M., Lorenzo, O., Ruperez, M., Konig, S., Wittig, B. and Egido, J. ( 2000) Angiotensin II activates nuclear transcription factor κB through AT 1 and AT 2 in vascular smooth muscle cells: molecular mechanism. Circ Res 86: 1266-1272.
90. Sanada, F., Taniyama, Y., Azuma, J., Ikeuchi, K., Dosaka, N., Yokoi, T. et al. (2009) Hepatocyte growth factor, but not vascular endothelial growth factor, attenuates angiotensin II-induced endothelial progenitor cell senescence. Hypertension 53: 77-82.
91. Sasaki, K., Murohara, T., Ikeda, H., Sugaya, T., Shimada, T., Shintani, S. et al. (2002) Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis. J Clin Inves 109: 603-611.
92. Scheubel, R.J., Zorn, H., Silber, R.E., Kuss, O., Morawierz, H., Holtz, J. et al. (2003) Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 42: 2073-2080.
93. Serrano, A.L. and Andres, V. ( 2004) Telomeres and cardiovascular disease: does size matter ? Circ Res 94: 575-584.
94. Shearman, A.M., Cupples, L.A., Demissie, S., Peter, I., Schmid, C.H., Karasa, R.H. et al. (2003) Association between estrogen receptor alpha gene variation and cardiovascular disease. JAMA 290: 2263-2270.
95. Simoncini, T., Hafezi-Moghadam, A., Brazil, D.P., Ley, K., Chin, W.W. and Liao, J.K. ( 2000) Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407: 538-541.
96. Sowers, J.R. ( 2002) Hypertension, angiotensin ii, and oxidative stress. N Engl J Med 346: 1999-2001.
97. Splipak, M.G., Angela, B.G., Go, A.S., Fredrick, P.D., Canto, J.G. and Grady, D. ( 2001) Hormone therapy and in-hospital survival after myocardial infarction in postmenopausal women. Circulation 104: 2300-2304.
98. Stehlow, K., Werner, N., Berweiler, J., Link, A., Dirnagl, U., Priller, J. et al. (2003) Estrogen increases bone marrow-derived endothelia progenitor cell production and diminishes neointima formation. Circulation 107: 3059-3065.
99. Sugihara, S., Yamamoto, Y., Matsuura, T., Narazaki, G., Yamasaki, A., Igawa, G. et al. (2007) Age-related BM-MNC dysfunction hampers neovascularization. Mech Ageing Dev 128: 511-516.
100. Tanaka, M., Kyo, S., Takakura, M., Kanaya, T., Segawa, T., Yamashita, K. et al. (1998) Expression of telomerase activity in human endometrium is localized to epithelial glandular cells and regulated in a menstrual phase-dependent manner correlated 1with cell proliferation. Am J Pathol 153: 1985-1991.
101. Touyz, R.M. ( 2004) Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 44: 248-252.
102. Touyz, R.M., Endemann, D., He, G., Li, J.S. and Schiffrin, E.L. ( 1999) Role of AT 2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR. Hypertension 33: 366-372.
103. Urbich, C., Heeschen, C., Aisher, A., Dernbach, E., Zeiher, A.M. and Dimmeler, S. ( 2003) Relevance of monocyte features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 108: 2511-2516.
104. Urbich, C. and Dimmeler, S. ( 2004) Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 95: 343-353.
105. Valgimigli, M., Rigolin, G.M., Fucili, A., Porta, M.D., Soukhomovskaia, O., Malaguti, P. et al. (2004) CD34+ and endothelial progenitor cells in patients with various degree of congestive heart failure. Circulation 110: 1209-1212.
106. Vasa, M., Breitschopf, K., Zeiher, A.M. and Dimmeler, S. ( 2000) Nitric oxide activates telomerase and delays endothelial cell senescence. Circ Res 87: 540-542.
107. Vasa, M., Fichtlscherer, S., Adler, K., Aicher, A., Martin, H., Zeiher, A.M. et al. (2001 a) Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103: 2885-2890.
108. Vasa, M., Fichtlscherer, S., Aicher, A., Adler, K., Urbich, C., Martin, H. et al. (2001 b) Numbers and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89: e1-e7.
109. Ward, M.R., Stewart, D.J. and Kutryk, M.J. ( 2007) Endothelial progenitor cell therapy for the treatment of coronary disease, acute MI, and pulmonary arterial hypertension: current perspectives. Catheter Cardiovasc Interv 70: 983-998.
110. Wassmann, S., Werner, N., Czech, T. and Nickenig, G. ( 2006) Improvement of endothelial function by systemic transfusion of vascular progenitor cells. Circ Res 99: e74-e83.